Literature DB >> 27489952

Correlation of 3D FLAIR and Dopamine Transporter Imaging in Patients With Parkinsonism.

Se Won Oh1, Na-Young Shin2,3, Jae Jung Lee4, Seung-Koo Lee3, Phil Hyu Lee4, Soo Mee Lim2, Jin Woo Kim5.   

Abstract

OBJECTIVE: The purpose of this study is to evaluate direct in vivo visualization of nigrosome-1 in substantia nigra (SN) with 3D FLAIR imaging and its diagnostic value in predicting the intactness of presynaptic dopaminergic function of the nigrostriatal pathway.
MATERIALS AND METHODS: Forty-five patients showing parkinsonism who underwent both 3D FLAIR and dopamine transporter (DAT) imaging were recruited. In total, 90 SNs were reviewed on axial 3D FLAIR images. We regarded oval or linear hyperintensities on the posterolateral side of SN as intact nigrosome-1. Two neuroradiologists independently evaluated the appearance of nigrosome-1, and disagreements were settled by consensus. Kappa values for interrater agreement were calculated. Diagnostic performances of the appearance of nigrosome-1 for predicting presynaptic dopaminergic function on DAT imaging and Parkinson disease (PD) were calculated.
RESULTS: The diagnostic performances of a loss of nigrosome-1 on 3D FLAIR images were sensitivity of 85.7%, specificity of 85.4%, positive predictive value (PPV) of 83.7%, and negative predictive value (NPV) of 87.2% for predicting impaired presynaptic dopaminergic function on DAT imaging, and sensitivity of 94.7%, specificity of 76.9%, PPV of 85.7%, and NPV of 90.9% for predicting PD. When only oval hyperintensity was considered as intact nigrosome-1, its sensitivity and NPV were increased up to 95.2% and 91.7%, respectively, for predicting impaired presynaptic dopaminergic function on DAT imaging, and both increased to 100% for predicting PD. Interobserver agreement for the appearance of nigrosome-1 on 3D FLAIR images was substantial (κ = 0.625).
CONCLUSION: Nigrosome-1 could be visualized on 3D FLAIR images, and its loss can be used to predict presynaptic dopaminergic function and to diagnose PD with high accuracy.

Entities:  

Keywords:  3D FLAIR; Parkinson disease; dopamine transporter imaging; nigrosome-1; parkinsonism

Mesh:

Substances:

Year:  2016        PMID: 27489952     DOI: 10.2214/AJR.16.16092

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  Clinical utility of visualisation of nigrosome-1 in patients with Parkinson's disease.

Authors:  Albert Stezin; Rajini M Naduthota; Ragasudha Botta; Shriram Varadharajan; Abhishek Lenka; Jitender Saini; Ravi Yadav; Pramod Kumar Pal
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

Review 2.  Nigrosome 1 imaging: technical considerations and clinical applications.

Authors:  Eung Yeop Kim; Young Hee Sung; Jongho Lee
Journal:  Br J Radiol       Date:  2019-06-05       Impact factor: 3.039

3.  Differential involvement of nigral subregions in idiopathic parkinson's disease.

Authors:  Young Hee Sung; Jongho Lee; Yoonho Nam; Hyeong-Geol Shin; Young Noh; Dong Hoon Shin; Eung Yeop Kim
Journal:  Hum Brain Mapp       Date:  2017-10-24       Impact factor: 5.038

4.  Utility of Imaging of Nigrosome-1 on 3T MRI and Its Comparison with 18F-DOPA PET in the Diagnosis of Idiopathic Parkinson Disease and Atypical Parkinsonism.

Authors:  Heena Kathuria; Sahil Mehta; Chirag K Ahuja; Kamalesh Chakravarty; Sucharita Ray; Bhagwant Rai Mittal; Paramjeet Singh; Vivek Lal
Journal:  Mov Disord Clin Pract       Date:  2020-10-02

5.  Fast 3 T nigral hyperintensity magnetic resonance imaging in Parkinson's disease.

Authors:  Gabriella Hernadi; David Pinter; Szilvia Anett Nagy; Gergely Orsi; Samuel Komoly; Jozsef Janszky; Norbert Kovacs; Gabor Perlaki
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 6.  Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism.

Authors:  Nicola Pavese; Yen F Tai
Journal:  Mov Disord Clin Pract       Date:  2018-02-22

7.  Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding?

Authors:  Carolin Gramsch; Iris Reuter; Oliver Kraff; Harald H Quick; Christian Tanislav; Florian Roessler; Cornelius Deuschl; Michael Forsting; Marc Schlamann
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

8.  The clinical application of nigrosome 1 detection on high-resolution susceptibility-weighted imaging in the evaluation of suspected Parkinsonism: The real-world performance and pitfalls.

Authors:  Jungbin Lee; A Leum Lee; Jeong-Ho Park; Ji Eun Moon; Jung-Mi Park; Sang Joon Kim; Kee-Hyun Chang
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.